Advances in radiological imaging of gastrointestinal tumors

Critical Reviews in Oncology/Hematology

Volumn 69, Issue 2, 2009, Pages 153-167

  Hoeffel, C ^a   Mule S ^b   Romaniuk, B ^c   Ladam Marcus, V ^a   Bouche O ^a   Marcus, C ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c LERI IUT Reims Châlons Charleville   (France)

Author keywords

Abdominal; Computed tomography; Gastrointestinal; Magnetic resonance imaging; Tumor; Ultrasound

Indexed keywords

CONTRAST MEDIUM; ECHO CONTRAST MEDIUM; ENEMA; FERUCARBOTRAN; GADOBENATE DIMEGLUMINE; GADOLINIUM; IRON OXIDE; MANGAFODIPIR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

CANCER DIAGNOSIS; CANCER MORPHOLOGY; CANCER STAGING; CLINICAL EVALUATION; COLORECTAL CARCINOMA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; GASTROINTESTINAL TRACT; GASTROINTESTINAL TUMOR; HUMAN; IONIZING RADIATION; LIVER PERFUSION; LIVER TUMOR; LYMPH NODE METASTASIS; MICROBUBBLE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; RECOMMENDED DRUG DOSE; REVIEW; SPECTROSCOPY;

COLONOGRAPHY, COMPUTED TOMOGRAPHIC; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; RADIOGRAPHIC IMAGE ENHANCEMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149165204     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.06.011     Document Type: Review

References (80)

1. Pickhardt P.J., Choi J.R., Hwang I., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349 (2003) 2191-2200
2. Glick S. Will 3 D virtual dissection display prove to be the display format for reviewing CT colonography examinations?. Radiology 244 (2007) 629-630
3. Rex D.K., and Lieberman D. ACG colorectal cancer prevention action plan: update on CT-colonography. Am J Gastroenterol 101 (2006) 1410-1413
4. Pickardt P.J., Taylor A.J., Kim D.H., Reichelderfer M., Gopal D.V., and Pfau P.R. Screening for colorectal neoplasia with CT colonography: initial experience from the first year of coverage by third-party payers. Radiology 241 (2006) 417-425
5. Kim D.H., Pickhardt P.J., Taylor A.J., et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 357 (2007) 1403-1412
6. Johnson C.D., MacCarty R.L., Welch T.J., et al. Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. Clin Gastroenterol Hepatol 2 (2004) 314-321
7. Copel L., Sosna J., Kruskal J.B., Raptopoulos V., Farrell R.J., and Morrin M.M. CT colonography in 546 patients with incomplete colonoscopy. Radiology 244 (2007) 471-478
8. Kim S.H., Lee J.M., Eun H.W., et al. Two- versus three-dimensional colon evaluation with recently developed virtual dissection software for CT colonography. Radiology 244 (2007) 852-864
9. Mang T., Peloschek P., Plank C., et al. Effect of computer-aided detection as a second reader in multidetector-row CT colonography. Eur Radiol 17 (2007) 2598-2607
10. Hartmann D., Bassler B., Schilling D., et al. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology 238 (2006) 143-149
11. Kinner S., and Lauenstein T.C. MR colonography. Radiol Clin North Am 45 (2007) 377-387
12. Ajaj W., Ruehm S.G., Gerken G., and Goyen M. Strengths and weaknesses of dark-lumen MR colonography: clinical relevance of polyps smaller than 5 mm in diameter at the moment of their detection. J Magn Reson Imaging 24 (2006) 1088-1094
13. Florie J., Jensch S., Nievelstein R.A., et al. MR colonography with limited bowel preparation compared with optical colonoscopy in patients at increased risk for colorectal cancer. Radiology 243 (2007) 122-131
14. Kuehle C.A., Langhorst J., Ladd S.C., et al. Magnetic resonance colonography without bowel cleansing: a prospective cross-sectional study in a screening population. Gut 56 (2007) 1079-1085
15. Ajaj W., Lauenstein T.C., Pelster G., et al. MR colonography in patients with incomplete conventional colonoscopy. Radiology 234 (2005) 452-459
16. Bodily K.D., Fletcher J.G., Solem C.A., et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography-correlation with endoscopic and histologic findings of inflammation. Radiology 238 (2006) 505-516
17. Megibow A.J., Babb J.S., Hecht E.M., et al. Evaluation of bowel distension and bowel wall appearance by using neutral oral contrast agent for multidetector row CT. Radiology 238 (2006) 87-95
18. Arlsan H., Etlik O., Kayan M., Harman M., Tuncer Y., and Temizoz O. Peroral CT enterography with lactulose solution: preliminary observations. AJR 185 (2005) 1173-1179
19. Glockner J.F., Hu H.H., Stanley D.W., et al. Parallel MR imaging: a user's guide. Radiographics 25 (2005) 1279-1297
20. Pilleul F., Penigaud M., Milot L., Saurin J.C., Chayvialle J.A., and Valette P.J. Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 241 (2006) 796-801
21. Boudiaf M., Jaff A., Soyer P., Bouhnik Y., Hamzi L., and Rymer R. Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 233 (2004) 338-344
22. Romano S., De Lutio E., Rollandi G.A., et al. Multidetector computed tomography enteroclysis (MDCT-E) with neutral enteral and IV contrast enhancement in tumor detection. Eur Radiol 15 (2005) 1178-1183
23. Hara A.K., Leighton J.A., Sharma V.K., and Fleischer D.E. Small bowel: preliminary comparison of capsule endoscopy with barium study and CT. Radiology 230 (2004) 260-265
24. Caspari R., von Falkenhausen M., Krautmacher C., Schild H., Heller J., and Sauerbruch T. Comparison of capsule endoscopy and magnetic resonance imaging for the detection of polyps of the small intestine in patients with familial adenomatous polyposis or with Peutz-Jeghers' syndrome. Endoscopy 36 (2004) 1054-1059
25. Correas J.M., Bridal L., Lesavre A., Méjean A., Claudon M., and Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11 (2001) 1316-1328
26. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 17 (2007) 195-2008
27. Catala V., Nicolau C., Vilana R., et al. Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17 (2007) 1066-1073
28. Dai Y., Chen M.H., Yin S.S., et al. Focal liver lesions: can Sonovue-enhanced ultrasound be used to differentiate malignant from benign lesions?. Invest Radiol 42 (2007) 596-603
29. Burns P., and Wilson S. Focal liver masses: enhancement patterns on contrast-enhanced images-concordance of US scans with CT scans and MR images. Radiology 242 (2007) 162-174
30. Quaia E., D'Onofrio M., Palumbo A., Rossi S., Bruni S., and Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16 (2006) 1599-1609
31. Konopke R., Bunk A., and Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 33 (2007) 1515-1526
32. Francazani A.L., Burdick L., Borzio M., et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34 (2001) 1109-1112
33. Nicolau C., Vilana R., and Bru C. The use of contrast-enhanced ultrasound in the management of the cirrhotic patient and for detection of HCC. Eur Radiol 14 (2004) 63-71
34. Itoh, Hirooka Y., Itoh A., et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 100 (2005) 144-152
35. Kitano M., Kudo M., Maekawa K., et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53 (2004) 854-859
36. D'Onofrio M., Mansueto G., Vasori S., Falconi M., and Procacci C. Contrast-enhanced ultrasonographic detection of small pancreatic insulinoma. J Ultrasound Med 22 (2003) 413-417
37. Finlay I. Preoperative staging for rectal cancer. BMJ 333 (2006) 766-767
38. MERCURY Study group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;14:7572-7579.
39. Beets-Tan R.G., and Beets G.L. Rectal cancer: review with emphasis on MR imaging. Radiology 232 (2004) 335-346
40. Lohan D.G., Alhajeri A.N., Cronin C.G., Roche C.J., and Murphy J.M. MR enterography of small-bowel lymphoma: potential for suggestion of histologic subtype and the presence of underlying celiac disease. AJR 190 (2008) 287-293
41. Chen C.Y., Hsu J.S., Wu D.C., et al. Gastric cancer: preoperative local staging with 3D multidetector row CT-correlation with surgical and histopathological results. Radiology 242 (2007) 472-482
42. Kim K.W., Kim A.Y., Park S.H., et al. Small (or = 2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI. AJR 182 (2004) 1233-1240
43. Soyer P., Pocard M., Boudiaf M., et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathological findings. Radiology 231 (2004) 413-420
44. Sahani D., Mehta A., Blake M., Prasad S., Harris G., and Saini S. Preoperative hepatic vascular evaluation with CT and MR angiography: implications for surgery. Radiographics 24 (2004) 1367-1380
45. Larsen L.P., Rosenkilde M., Christensen H., et al. Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?. Eur J Radiol (2007)
46. Bellomi M., Petralia G., Sonzogni A., Zampino M.G., and Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 244 (2007) 486-493
47. Sahani D.V., Holalkere N.S., Mueller P.R., and Zhu A.X. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience. Radiology 243 (2007) 736-743
48. Margolis D.J., Hoffman J.M., Herfkens R.J., Jeffrey R.B., Quon A., and Gambhir S.S. Molecular imaging techniques in body imaging. Radiology 245 (2007) 333-356
49. Reinsberg S.A., Payne G.S., Riches S.F., et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR 188 (2007) 91-98
50. Neil J.J. Measurement of water motion (apparent diffusion) in biological systems. Concepts Magn Reson 9 (1997) 385-401
51. Lyng H., Haraldseth O., and Rofstad E.K. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 43 (2000) 828-836
52. Valonen P.K., Lehtimaki K.K., Vaisanen T.H., et al. Water diffusion in a rat glioma during ganciclovir-thylidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density. J Magn Reson Imaging 19 (2004) 389
53. Minard K.R., Holtom G.R., Kathmann L.E., Majors P.D., Thrall B.D., and Wind R.A. Simultaneous 1 H PFG-NMR and confocal microscopy of monolayer cell cultures: effects of apoptosis and necrosis on water diffusion and compartmentalization. Magn Reson Med 52 (2004) 495-505
54. Ichikawa T., Ertuk S.M., Motosugi U., et al. High-b-value diffusion-weighted MRI in colorectal cancer. AJR 187 (2006) 181-184
55. Taouli B., Vilgrain V., Dumont E., Daire J.L., Fan B., and Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226 (2003) 71-78
56. Honosuma T., Tozaki M., Ichiba N., et al. Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magn Reson Med Sci 5 (2006) 173-177
57. Ichikawa T., Ertuk S.M., Motogushi U., et al. High-B-value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR 188 (2007) 409-414
58. Koh D.M., Scurr E., Collins D., et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. Am J Roentgenol 188 (2007) 1001-1008
59. Moteki T., and Horikoshi H. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging 24 (2006) 637-645
60. Naganawa S., Kawai H., Fukatsu H., Sakurai Y., Aoki I., and Miura S. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 31 (2005) 175-186
61. Balci N.C., and Semelka R.C. Contrast agents for MR imaging of the liver. Radiol Clin North Am 43 (2005) 887-898
62. Gandhi S.N., Brown M.A., Wong J.G., Aguirre D.A., and Sirlin C.B. MR contrast agents for liver imaging: what, when, how?. Radiographics 26 (2006) 1621-1636
63. Schneider G., Maas R., Schultze Kool L., et al. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison. Invest Radiol 38 (2003) 85-94
64. Soyer P. Will ferumoxides-enhanced MR imaging replace CT during arterial portography for the detection of hepatic metastases? Prologue to a promising future. Radiology 201 (1996) 610-611
65. Kim Y.K., Kwak H.S., Kim C.S., Chung G.H., Han Y.M., and Lee J.M. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 238 (2006) 531-541
66. Onishi H., Murakami T., Kim T., et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 239 (2006) 131-138
67. Ward J., Robinson P.J., Guthrie J.A., et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237 (2005) 170-180
68. Leong-poi H., Christiansen J., Heppner P., et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 111 (2005) 3248-3254
69. Weller G.E., Wong M.K., Modzelewski R.A., et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65 (2005) 533-539
70. Klibanov A.L. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 41 (2006) 354-362
71. Behm C.Z., and Lindner J.R. Cellular and molecular imaging with targeted contrast ultrasound. Ultrasound Q 22 (2006) 67-72
72. Harisinghani M.G., Dixon W.T., Saksena M.A., Brachtel E., Blezek D.J., and Dhawale P.J. MR lymphangiography, imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 24 (2004) 867-878
73. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Non-invasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
74. Koh D.M., Brown G., Temple L., et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 231 (2004) 91-99
75. Von Schulthess G.K., Steinert H.C., and Hany T.F. Integrated PET/CT: current applications and future directions. Radiology 238 (2006) 405-422
76. Cohade C., Osman M., Leal J., and Wahl R.L. Direct comparison of (18) F-FDG PET and PET/CT in patients with CRC carcinoma. J Nucl Med 44 (2003) 1797-1803
77. Mertz H.R., Sechopoulos P., Delbeke D., and Leach S.D. EUS, PET, and CT scanning for evaluation of pancreatic carcinoma. Gastrointest Endosc 52 (2000) 367-371
78. Heinrich S., Goerres G.W., Schafer M., Sagmeister M., Bauerfeind P., and Pestalozzi B.C. Positron emission tomography/computed tomography influences on the management of respectable pancreatic cancer and its cost-effectiveness. Ann Surg 242 (2005) 235-243
79. Seemann M.D. Whole-body PET/MRI: the future in oncological imaging. Technol Cancer Res Treat 4 (2005) 577-582
80. Seemann M.D., and Gaa J. Images in cardiovascular medicine. Cardiac metastasis: visualization with positron emission tomography, magnetic resonance imaging, positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging. Circulation 22 (2005) 112